Lowbury, E. J. L., Iones, R. J. Treatment and prophylaxis for pseudomonas infections. In:Brown, M. R. W. (ed.): Resistance ofPseudomonas aeruginosa. Wiley, London 1975, pp. 237–269.
Baltch, A. L., Hammer, M., Smith, R. P., Sutphen, N. Pseudomonas aeruginosa bacteremia. Susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance. J. Lab. Clin. Med. 94 (1979) 201–214.
Jones, R. J., Roe, E. A., Gupta, J. L. Controlled trials of a polyvalent pseudomonas vaccine in burns. Lancet II (1979) 977–983.
Mutharia, L. M., Nicas, T. J., Hancock, R. E. W. Outer membrane proteins ofPseudomonas aeruginosa serotype strains. J. Infect. Dis. 146 (1982) 770–779.
Gillebrand, jr., H. E., Parker, M. G., Matthews, J. M., Berg, R. D. Use of a purified outer membrane protein F (porin) preparation ofPseudomonas aeruginosa as a protective vaccine in mice. Infect. Immun. 44 (1984) 49–54.
Mizuno, T., Kageyama, U. Isolation and characterization of major outer membrane proteins ofPseudomonas aeruginosa strain PAO with special reference to peptidoglycan-associated protein. J. Biochem. 86 (1979) 979–989.
Peterson, G. L. A simplification of the protein assay method ofLowry et al. which is more generally applicable. Anal. Biochem. 83 (1977) 346–356.
Lugtenberg, B., Meijers, J., Peters, R., van der Hoek, P., van Alphen, L. Electrophoretic resolution of the major outer membrane proteins of E. coli K 12 into 4 bands. FEBS LeH. 58 (1975) 254–258.
Towbin, M., Staehlin, T., Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gel to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350–4354.
Reed, L. J., Muench, H. A simple method for estimating fifty percent end points. Am. J. Hyg. 27 (1938) 493–497.
Merle, P., Robbel, J., Hungerer, K. D. A new polyvalent Pseudomonas vaccine. Behring Inst. Mitt. 76 (1984) 113–120.